Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride exposure harms tadpole reproduction and hormone balance.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

Women with different PCOS types have similar fertility treatment results.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

An ovarian tumor can cause high male hormones in postmenopausal women.

PCOS is a major cause of infertility in women of childbearing age.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.